United States · FDA National Drug Code directory
SELEGILINE HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60505-0055_2a0cd745-7f62-19e1-d623-fea131789df0
- Product NDC
- 60505-0055
- Form
- CAPSULE
- Composition / generic term
- SELEGILINE HYDROCHLORIDE
- Labeler
- Apotex Corp.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 19970715
- Source listing expiry
- 20261231
Source-listed ingredients
- SELEGILINE HYDROCHLORIDE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 CAPSULE in 1 BOTTLE (60505-0055-1) · 60505-0055-1
- 1000 CAPSULE in 1 BOTTLE (60505-0055-2) · 60505-0055-2
- 500 CAPSULE in 1 BOTTLE (60505-0055-3) · 60505-0055-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →